Cancer Incidence in Southwest of Iran: First Report from Khuzestan Population-Based Cancer Registry, 2002-2009

  • Talaiezadeh, Abdolhassan (Department of Surgery, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences) ;
  • Tabesh, Hamed (Department of Biostatistics and Epidemiology, Faculty of Health, Ahvaz Jundishapur University of Medical Sciences) ;
  • Sattari, Alireza (Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences) ;
  • Ebrahimi, Shahram (Cancer, Petroleum, and Environmental Pollutants Research Center, Ahvaz Jundishapur University of Medical Sciences)
  • Published : 2013.12.31


Background: Cancer incidence rates are increasing particularly in developing countries. It is crucial for policy makers to know basic cancer epidemiology in each region to design comprehensive prevention plans. There have hitherto been no population-based data available for cancer in Khuzestan province. The present report is a first from the regional population-based cancer registry for the period of 2002-2009. Materials and Methods: Data were collected retrospectively reviewing all new cancer patients whom were registered in Khuzestan province cancer registry during an 8-year period (2002-2009). All cases were coded based on the ICD-O-3 coding system and collected data were computerized using SPSS (Chicago, IL) software, version 11.5. The age standardized incidence rates (ASRs) per 100,000 person-year for all cancers were computed using the indirect method of standardization to the world population. Results: During the 8-year study period, 16,801 new cancer cases were registered. Based on the computed ASRs, the five most frequent malignancies in females were breast (26.4 per 100,000), skin (13.6), colorectal (5.72), stomach (4.31) and bladder(4.07) and in males, the five most frequent were skin (16.0 per 100,000), bladder (10.7),prostate (7.64), stomach (7.17), and colorectal (6.32).The ASR for all malignancies in women was 92.5 per 100,000, and that for men was 87.4. Conclusions: The observed patterns from the analysis of Khuzestan cancer registry data will lead to better understanding of the epidemiology of various malignancies in this part ofthe country and consequently provide a useful guide for authorities to make efficacious decisions and policies about a cancer control program for south-west Iran.


  1. Tsugane S (2005). Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci, 96, 1-6.
  2. Wang YC, Wei LJ, Liu JT, Li SX, Wang QS. (2012). Comparison of Cancer Incidence between China and the USA. Cancer Biol Med, 9, 128-32.
  3. Sobin LH (1969). Cancer in Afghanistan. Cancer, 23, 678-88.<678::AID-CNCR2820230322>3.0.CO;2-4
  4. Taheri NS, Bakhshandehnosrat S, Tabiei MN, et al (2012). Epidemiological Pattern of Breast Cancer in Iranian Women: Is there an Ethnic Disparity? Asian Pac J Cancer Prev, 13, 4517-20.
  5. Babaei M, Pourfarzi F, Yazdanbod A, et al (2010). Gastric cancer in Ardabil, Iran--a review and update on cancer registry data. Asian Pac J Cancer Prev, 11, 595-9.
  6. Bener A, Ayub H, Kakil R, Ibrahim W (2008). Patterns of cancer incidence among the population of Qatar: a worldwide comparative study. Asian Pac J Cancer Prev, 9, 19-24.
  7. Boffetta P, Parkin D M (1994). Cancer in developing countries. CA: Cancer J Clin, 44, 81-90.
  8. Akbari M E, Hosseini S J, Rezaee A, et al (2008). Incidence of genitourinary cancers in the Islamic Republic of Iran: a survey in 2005. Asian Pac J Cancer Prev, 9, 549-52.
  9. Armstrong B K, Kricker A (2007). Sun exposure and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev, 16, 396-400.
  10. Burger M, Catto J W, Dalbagni G, et al (2013). Epidemiology and risk factors of urothelial bladder cancer. Eur Urol, 63, 234-41
  11. Center M M, Jemal A, Lortet-Tieulent J, et al (2012). International variation in prostate cancer incidence and mortality rates. Eur Urol, 61, 1079-92.
  12. Chang J S, Wrensch M R, Hansen H M, et al (2008). Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer, 123, 2095-104.
  13. Chang JS, Wrensch MR, Hansen HM, et al (2009). Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans. Carcinogenesis, 30, 78-87.
  14. Chu H, Wang M, Zhang Z (2013). Bladder cancer epidemiology and genetic susceptibility. J Biomed Res, 27, 170.
  15. Clemmensen J (1967). Racial and geographical factors in tumour incidence: Background and basis of studies. Racial and geographical factors in tumor incidence. University of Edinburgh Pfizer Medicai Monography, 2, 3-16.
  16. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
  17. Fritz A, Percy C, Jack A, et al (2000). International Classification of Diseases for Oncology, 3rd edn. World Health Organ: Geneva.
  18. Haghighi P, Nabizadeh I, Asvadi S, Mohallatee E (1971). Cancer in southern Iran. Cancer, 27, 965-977.<965::AID-CNCR2820270432>3.0.CO;2-F
  19. Hajiani E, Masjedizadeh R, Hashemi J, Azmi M, Rajabi T (2005). Risk factors for hepatocellular carcinoma in Southern Iran. Saudi Med J, 26, 974-7.
  20. Islami F, Pourshams A, Nasrollahzadeh D, et al (2009). Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ: Brit Med J, 338, 929.
  21. Izquierdo J, Schoenbach V (2000). The potential and limitations of data from population-based state cancer registries. Am J Public Health, 90, 695.
  22. Japoni A, Alborzi A, Zarenezhad M, Ranjbar R (2010). Changing prevalence of Helicobacter pylori in south of Iran. Iranian J Clin Infectious Diseases, 5, 65-9.
  23. Jemal A, Siegel R, Xu J, Ward E (2010). Cancer statistics, 2010. CA: Cancer J Clin, 60, 277-300.
  24. Masoompour SM, Yarmohammadi H, Rezaianzadeh A, Lankarani KB (2011). Cancer incidence in southern Iran, 1998–2002: Results of population-based cancer registry. Cancer Epidemiol, 35, 42-7.
  25. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M (2009). Cancer incidence in Tehran Metropolis: The first report from the Tehran Population-Based Cancer Registry. Arch Iran Med, 12, 15-23.
  26. Mokarian F, Ramezani MA, Heydari K, Tabatabaeian M, Tavazohi H (2011). Epidemiology and trend of cancer in Isfahan 2005-2010. J Res Med Sci, 16, 1228-33.
  27. Mosavi-Jarrahi A, Mohagheghi MA (2006). Epidemiology of esophageal cancer in the high-risk population of Iran. Asian Pac J Cancer Prev, 7, 375-80.
  28. Mosavi-Jarrahi A, Mohagheghi MA, Kalaghchi B et al (2009). Estimating the incidence of leukemia attributable to occupational exposure in Iran. Asian Pac J Cancer Prev, 10, 67-70.
  29. Park HJ, Park EH, Jung KW, et al (2012). Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008. Korean J Hematol, 47, 28-38.
  30. Parkin D M, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA: Cancer J Clin, 55, 74-108.
  31. Petridou ET, Dikalioti SK, Skalkidou A, et al (2007). Sun exposure, birth weight, and childhood lymphomas: a case control study in Greece. Cancer Causes Control, 18, 1031-1037.
  32. Ploeg M, Aben KK, Kiemeney LA (2009). The present and future burden of urinary bladder cancer in the world. World J Urol, 27, 289-93.
  33. Radmard AR (2010). Five common cancers in Iran. Arch Iran Med, 13, 143-6.
  34. Roshandel G, Sadjadi A, Aarabi M (2012). Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008. Arch Iran Med, 15, 196-200.
  35. Roshandel G, Semnani S, Aarabi M, et al (2011). Lymphomas in Golestan Province of Iran: Results of a Population-based Cancer Registry. Asian Pac J Cancer Prev, 12, 219-22.
  36. Saalabian M (1989). Registry of neoplastic diseases. Shiraz University of Medical Sciences, Medical School and Iranian Cancer Society, Fars Province.
  37. Sadjadi A, Malekzadeh R, Derakhshan MH, et al (2003). Cancer occurrence in Ardabil: Results of a population based Cancer Registry from Iran. Int J Cancer, 107, 113-8.
  38. Sadjadi A, Nooraie M, Ghorbani A, et al (2007). The incidence of prostate cancer in Iran: results of a population-based cancer registry. Arch Iran Med, 10, 481-5.
  39. Sen U, Sankaranarayanan R, Mandal S, et al (2002). Cancer patterns in eastern India: the first report of the Kolkata cancer registry. Int J Cancer, 100, 86-91.
  40. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics for hispanics/latinos, 2012. CA: Cancer J Clin, 62, 283-98.

Cited by

  1. Histopathologic Characterization of Prostate Diseases in Madinah, Saudi Arabia vol.15, pp.10, 2014,
  2. Fruit and Vegetable Intake in Relation to Prostate Cancer in Iranian Men: A Case-Control Study vol.15, pp.13, 2014,
  3. Treatment Interruption During Concurrent Chemoradiotherapy of Uterine Cervical Cancer; Analysis of Factors and Outcomes vol.15, pp.14, 2014,
  4. Cancer Notification at a Referral Hospital of Kermanshah, Western Iran (2006-2009) vol.16, pp.1, 2015,
  5. Diet and Colorectal Cancer Risk in Asia - a Systematic Review vol.16, pp.13, 2015,
  6. Adjuvant Chemotherapy and Prognostic Factors in Stage II Colon Cancer - Izmir Oncology Group Study vol.16, pp.6, 2015,
  7. A Systematic Review Over the Incidence of Colorectal Cancer in Iran vol.3, pp.1, 2015,
  8. Changing Epidemiology of Common Cancers in Southern Iran, 2007-2010: A Cross Sectional Study vol.11, pp.5, 2016,
  9. gene polymorphism and prostate cancer susceptibility in an Iranian population vol.3, pp.6, 2016,
  10. Association between polymorphisms in TP53 and MDM2 genes and susceptibility to prostate cancer vol.13, pp.4, 2017,
  11. Evaluation of a 3-base pair indel polymorphism within pre-microRNA-3131 in patients with prostate cancer using mismatch polymerase chain reaction-restriction fragment length polymorphism vol.7, pp.4, 2017,
  12. Cervical cancer in Iran: integrative insights of epidemiological analysis vol.8, pp.3, 2018,